PROBABLE INVIVO INDUCTION OF DIFFERENTIATION BY RETINOIC ACID OF PROMYELOCYTES IN ACUTE PROMYELOCYTIC LEUKEMIA
PROBABLE INVIVO INDUCTION OF DIFFERENTIATION BY RETINOIC ACID OF PROMYELOCYTES IN ACUTE PROMYELOCYTIC LEUKEMIA
复制标题
DOI:
10.1111/j.1365-2141.1984.tb02910.x
复制
发表时间:
1984-01-01
影响因子:
6.5
通讯作者:
NILSSON, B
中科院分区:
文献类型:
--
作者:
NILSSON, B
A 30-yr-old woman was diagnosed as having an acute promyelocytic leukemia in Sept. 1981. Chemotherapeutic courses of duanomycin, ara-C [cytosine arabinoside], thioguanine and prednisolone were administered, resulting in a complete remission. A relapse occurred in Jan. 1982. Chemotherapy did not lead to a 2nd complete remission; neutropenia persisted with a marked left shift of the marrow granulopoiesis. Courses of chemotherapy were given throughout the study. In Sept. 1982, marrow promyelocytes markedly increased, making up 51% of the nucleated cells. One month later the situation was unchanged; 13-cis-retinoic acid (1 mg/kg) was administered by mouth. Gradually the marrow proportion of promyelocytes decreased to normal levels. The peripheral blood and marrow were still normal after 20 wk of treatment with retinoic acid. Thus, retinoic acid seemed to have been inducing differentiation in an abnormally increased, maturation-deficient population of promyelocytes in a patient with acute promyelocytic leukaemia.